PAI Partners close to buying France's SGD Pharma from China Jianyin Investment

PAI Partners close to buying France's SGD Pharma from China Jianyin Investment

Photo: CDC / Unsplash

Private equity firm PAI Partners is close to acquiring France’s SGD Pharma, a supplier of COVID-19 vaccine vials, from China Jianyin Investment (JIC), a source with direct knowledge of the transaction told Reuters.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter